What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma (Part 3 of a 4-Part Series) - Slide Archive | Research To Practice

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma (Part 3 of a 4-Part Series) - Slide Archive

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma (Part 3 of a 4-Part Series)

Please note that slides and other materials provided are for review only and not to be repurposed or published.

A 4-Part Friday Satellite Symposia Series Preceding the 63^rd ASH Annual Meeting and Exposition

Friday, December 10, 2021

MODULE 1: Contemporary Treatment Planning for Patients with Newly Diagnosed Multiple Myeloma (MM) — Morie A Gertz, MD, MACP

MODULE 2: Chimeric Antigen Receptor (CAR) T-Cell Therapy for MM — Larry D Anderson Jr, MD, PhD

MODULE 3: Other Approved and Investigational BCMA-Targeted Strategies for R/R MM — Peter Voorhees, MD

MODULE 4: Integration of Other Novel Agents into the Management of R/R Disease — Robert Z Orlowski, MD, PhD

MODULE 5: Novel Investigational Agents and Strategies — Irene M Ghobrial, MD